This Cancer Drug Is So Effective, The FDA Approved It Immediately
June 11, 2017
A new cancer drug has overwhelmingly helped shrink or eradicate tumors in patients whose cancer had resisted every other form of treatment.
The results, published in the journal Science, are so striking that the Food and Drug Administration already has approved the drug.
Image credit: Merck
The study followed 86 cancer patients with tumors of the pancreas, prostate, uterus or bone. Each patient was given pembrolizumab, which also goes by the brand name Keytruda.
After taking the drug, 66 patients had their tumors shrink substantially and stabilize, instead of continuing to grow. Among them were 18 patients whose tumors vanished and have not returned.
According to the New York Times, this is the first time a drug has been approved for use against tumors that share a particular genetic profile, regardless of where they appear in the body.
Dr. Jack Jacoub, a medical oncologist and director of thoracic oncology at Memorial Care Cancer Institute at Orange Coast Memorial Medical Center, said "The FDA doesn't take these kinds of things lightly. The data was so good, they had to approve it."
Click Here For The Most Popular On Sunny Skyz
Boy With Down Syndrome Nails The Whitney Houston Challenge, And The Crowd Goes Wild
Husband Rents Mall Store To Share His Late Wife's Beloved Christmas Display
The ‘Grandma Stand’ Is Bringing Comfort And Connection, One Conversation At A Time
This Priest Secretly Became A Masked Wrestler To Fund An Orphanage
The Funniest Wildlife Photos Of 2025 Are Here — And They’re Hilarious
This 30-Year-Old’s Christmas Gift To His Mom Is Going Viral
Dad Jokes With Tom Hardy And His Dad
After 2 Years Apart, Siblings In Foster Care Are Finally Reunited
The Hug That Went Viral On Facebook
You Have To See This 'Piggy Train' Trotting Through The Snow
She’s Been Helping Hungry Children For Years — This Christmas, Someone Helped Her
